Lista de obras - Ander Urruticoechea - Dominio Público Uruguay

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.

artículo científico publicado en 2011

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment ⬇️

artículo científico publicado el 1 de diciembre de 2012

Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence

artículo científico publicado en 2010

Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

artículo científico publicado en 2012

Biological convergence of cancer signatures

artículo científico publicado en 2009

Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.

artículo científico publicado en 2010

Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors

artículo científico publicado en 2013

Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice

artículo científico publicado en 2012

Eribulin mesylate in breast cancer

artículo científico publicado en 2013

Evidence for a link between TNFRSF11A and risk of breast cancer

article

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

artículo científico publicado en 2015

Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment.

artículo científico publicado en 2008

Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo

artículo científico publicado en 2008

Integrative analysis of a cancer somatic mutome

artículo científico

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

artículo científico publicado en 2011

Measurement of total and free docetaxel concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.

artículo científico publicado en 2015

Molecular response to aromatase inhibitor treatment in primary breast cancer

artículo científico publicado en 2007

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

artículo científico publicado en 2009

Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.

artículo científico publicado en 2010

Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC).

artículo científico publicado en 2007

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

artículo científico publicado en 2014

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

artículo científico publicado en 2017

Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy

artículo científico publicado en 2014

Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women

artículo científico publicado en 2010

Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer

artículo científico publicado en 2007

Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis

artículo científico publicado en 2017

RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis ⬇️

artículo científico publicado el 10 de abril de 2012

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based T

article

Recent advances in cancer therapy: an overview.

artículo científico publicado en 2010

Removal of the internal mammary sentinel node in breast cancer.

artículo científico publicado en 2009

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

artículo científico publicado en 2017

Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer

artículo científico publicado en 2004

VAV3 mediates resistance to breast cancer endocrine therapy.

artículo científico publicado en 2014

Lista de obras de Ander Urruticoechea

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment ⬇️

Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence

Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Biological convergence of cancer signatures

Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.

Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors

Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice

Eribulin mesylate in breast cancer

Evidence for a link between TNFRSF11A and risk of breast cancer

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment.

Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo

Integrative analysis of a cancer somatic mutome

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Measurement of total and free docetaxel concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.

Molecular response to aromatase inhibitor treatment in primary breast cancer

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.

Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC).

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy

Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women

Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer

Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis

RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis ⬇️

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based T

Recent advances in cancer therapy: an overview.

Removal of the internal mammary sentinel node in breast cancer.

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer

VAV3 mediates resistance to breast cancer endocrine therapy.